Skip to main content
TipRanks
Go Ultimate75% OFF

John Maraganore Insider Profile

18 Followers

John Maraganore, Director at Rapport Therapeutics, Inc., holds 9.41K shares in Rapport Therapeutics, Inc. (Ticker: RAPP), holds 24.20K shares in Takeda Pharmaceutical Company (Ticker: TAK), holds 230.80K shares in Alnylam Pharma (Ticker: ALNY). Most recently, John Maraganore Bought ― shares of Rapport Therapeutics, Inc. on Oct 22, 2026 for an estimated value of $248.80K.

John Maraganore's Trading History

RAPP
Rapport Therapeutics, Inc.
Oct 22, 2026DirectorInformative Buy248.80K$233.58K
CTY
City Therapeutics, Inc.
Oct 19, 2026DirectorUninformative Buy―$35.79M
TAK
Takeda Pharmaceutical Company
Jul 06, 2026DirectorUninformative Buy―$522.48K
COAG
Hemab Therapeutics Holdings, Inc.
May 04, 2026DirectorUninformative Buy―$1.40M
AGIO
Agios Pharma
May 24, 2022DirectorUninformative Buy33.44K$905.34K
ALNY
Alnylam Pharma
Dec 23, 2021CEO, DirectorUninformative Buy―$36.87M
BLUE
Bluebird Bio
Sep 18, 2017―Uninformative Buy39.43K$29.04K
RGLS
Regulus
Oct 11, 2012―Uninformative Buy―$50.19M
PROK
ProKidney
―Director――
KYMR
Kymera Therapeutics
―Director――
BEAM
Beam Therapeutics
―Director――

You May Also Like

John Maraganore insider profile FAQ

What is the percentage of profitable transactions made by John Maraganore?
The percentage of profitable transactions made by John Maraganore is 47%.
What is the average return per transaction made by John Maraganore?
The average return per transaction made by John Maraganore is 43.80%.
What stocks does John Maraganore hold?
John Maraganore holds: RAPP, ALNY, TAK, BEAM, KYMR, PROK, COAG, CTY, AGIO, BLUE, RGLS stocks.
What was John Maraganore’s latest transaction?
John Maraganore’s latest transaction was an Informative Buy of $248.80K.
What was John Maraganore's most profitable transaction?
John Maraganore’s most profitable transaction was an Informative Buy of BLUE stock on July 14, 2014. The return on the trade was 386.00%.
What is John Maraganore's role in Rapport Therapeutics, Inc.?
John Maraganore's role in Rapport Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.